The global Custom Oligonucleotide Synthesis Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Custom Oligonucleotide Synthesis Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Custom Oligonucleotide Synthesis Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Custom Oligonucleotide Synthesis Service in Commercial is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Custom Oligonucleotide Synthesis Service include GenScript, OriGene, BBI, Genewiz, Eurofins Genomics, Gene Oracle, SBS Genetech, Creative Biolabs and Bio Basic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Custom Oligonucleotide Synthesis Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Custom Oligonucleotide Synthesis Service.
Report Scope
The Custom Oligonucleotide Synthesis Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Custom Oligonucleotide Synthesis Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Custom Oligonucleotide Synthesis Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
GenScript
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Creative Biolabs
Bio Basic
Kaneka Eurogentec SA
AltaBioscience
Synbio Technologies
TriLink
Azenta Life Science
KareBay Biochem
Creative Biogene
Generi Biotech
Primetech
General Biosystems
Segment by Type
Standard Oligonucleotides
Micro-Oligonucleotides
Large-scale Oligonucleotides
Degenerate Primers
Long Oligos Synthesis
Segment by Application
Commercial
Academic Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Custom Oligonucleotide Synthesis Service companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Custom Oligonucleotide Synthesis Service 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Standard Oligonucleotides
1.2.3 Micro-Oligonucleotides
1.2.4 Large-scale Oligonucleotides
1.2.5 Degenerate Primers
1.2.6 Long Oligos Synthesis
1.3 麻豆原创 by Application
1.3.1 Global Custom Oligonucleotide Synthesis Service 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Commercial
1.3.3 Academic Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Custom Oligonucleotide Synthesis Service 麻豆原创 Perspective (2019-2030)
2.2 Custom Oligonucleotide Synthesis Service Growth Trends by Region
2.2.1 Global Custom Oligonucleotide Synthesis Service 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Custom Oligonucleotide Synthesis Service Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Custom Oligonucleotide Synthesis Service Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Custom Oligonucleotide Synthesis Service 麻豆原创 Dynamics
2.3.1 Custom Oligonucleotide Synthesis Service Industry Trends
2.3.2 Custom Oligonucleotide Synthesis Service 麻豆原创 Drivers
2.3.3 Custom Oligonucleotide Synthesis Service 麻豆原创 Challenges
2.3.4 Custom Oligonucleotide Synthesis Service 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Custom Oligonucleotide Synthesis Service Players by Revenue
3.1.1 Global Top Custom Oligonucleotide Synthesis Service Players by Revenue (2019-2024)
3.1.2 Global Custom Oligonucleotide Synthesis Service Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Custom Oligonucleotide Synthesis Service 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Custom Oligonucleotide Synthesis Service Revenue
3.4 Global Custom Oligonucleotide Synthesis Service 麻豆原创 Concentration Ratio
3.4.1 Global Custom Oligonucleotide Synthesis Service 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Custom Oligonucleotide Synthesis Service Revenue in 2023
3.5 Custom Oligonucleotide Synthesis Service Key Players Head office and Area Served
3.6 Key Players Custom Oligonucleotide Synthesis Service Product Solution and Service
3.7 Date of Enter into Custom Oligonucleotide Synthesis Service 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Custom Oligonucleotide Synthesis Service Breakdown Data by Type
4.1 Global Custom Oligonucleotide Synthesis Service Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Custom Oligonucleotide Synthesis Service Forecasted 麻豆原创 Size by Type (2025-2030)
5 Custom Oligonucleotide Synthesis Service Breakdown Data by Application
5.1 Global Custom Oligonucleotide Synthesis Service Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Custom Oligonucleotide Synthesis Service Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Custom Oligonucleotide Synthesis Service 麻豆原创 Size (2019-2030)
6.2 North America Custom Oligonucleotide Synthesis Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Custom Oligonucleotide Synthesis Service 麻豆原创 Size by Country (2019-2024)
6.4 North America Custom Oligonucleotide Synthesis Service 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Custom Oligonucleotide Synthesis Service 麻豆原创 Size (2019-2030)
7.2 Europe Custom Oligonucleotide Synthesis Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Custom Oligonucleotide Synthesis Service 麻豆原创 Size by Country (2019-2024)
7.4 Europe Custom Oligonucleotide Synthesis Service 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Custom Oligonucleotide Synthesis Service 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Custom Oligonucleotide Synthesis Service 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Custom Oligonucleotide Synthesis Service 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Custom Oligonucleotide Synthesis Service 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Custom Oligonucleotide Synthesis Service 麻豆原创 Size (2019-2030)
9.2 Latin America Custom Oligonucleotide Synthesis Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Custom Oligonucleotide Synthesis Service 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Custom Oligonucleotide Synthesis Service 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Custom Oligonucleotide Synthesis Service 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Custom Oligonucleotide Synthesis Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Custom Oligonucleotide Synthesis Service 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Custom Oligonucleotide Synthesis Service 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript
11.1.1 GenScript Company Detail
11.1.2 GenScript Business Overview
11.1.3 GenScript Custom Oligonucleotide Synthesis Service Introduction
11.1.4 GenScript Revenue in Custom Oligonucleotide Synthesis Service Business (2019-2024)
11.1.5 GenScript Recent Development
11.2 OriGene
11.2.1 OriGene Company Detail
11.2.2 OriGene Business Overview
11.2.3 OriGene Custom Oligonucleotide Synthesis Service Introduction
11.2.4 OriGene Revenue in Custom Oligonucleotide Synthesis Service Business (2019-2024)
11.2.5 OriGene Recent Development
11.3 BBI
11.3.1 BBI Company Detail
11.3.2 BBI Business Overview
11.3.3 BBI Custom Oligonucleotide Synthesis Service Introduction
11.3.4 BBI Revenue in Custom Oligonucleotide Synthesis Service Business (2019-2024)
11.3.5 BBI Recent Development
11.4 Genewiz
11.4.1 Genewiz Company Detail
11.4.2 Genewiz Business Overview
11.4.3 Genewiz Custom Oligonucleotide Synthesis Service Introduction
11.4.4 Genewiz Revenue in Custom Oligonucleotide Synthesis Service Business (2019-2024)
11.4.5 Genewiz Recent Development
11.5 Eurofins Genomics
11.5.1 Eurofins Genomics Company Detail
11.5.2 Eurofins Genomics Business Overview
11.5.3 Eurofins Genomics Custom Oligonucleotide Synthesis Service Introduction
11.5.4 Eurofins Genomics Revenue in Custom Oligonucleotide Synthesis Service Business (2019-2024)
11.5.5 Eurofins Genomics Recent Development
11.6 Gene Oracle
11.6.1 Gene Oracle Company Detail
11.6.2 Gene Oracle Business Overview
11.6.3 Gene Oracle Custom Oligonucleotide Synthesis Service Introduction
11.6.4 Gene Oracle Revenue in Custom Oligonucleotide Synthesis Service Business (2019-2024)
11.6.5 Gene Oracle Recent Development
11.7 SBS Genetech
11.7.1 SBS Genetech Company Detail
11.7.2 SBS Genetech Business Overview
11.7.3 SBS Genetech Custom Oligonucleotide Synthesis Service Introduction
11.7.4 SBS Genetech Revenue in Custom Oligonucleotide Synthesis Service Business (2019-2024)
11.7.5 SBS Genetech Recent Development
11.8 Creative Biolabs
11.8.1 Creative Biolabs Company Detail
11.8.2 Creative Biolabs Business Overview
11.8.3 Creative Biolabs Custom Oligonucleotide Synthesis Service Introduction
11.8.4 Creative Biolabs Revenue in Custom Oligonucleotide Synthesis Service Business (2019-2024)
11.8.5 Creative Biolabs Recent Development
11.9 Bio Basic
11.9.1 Bio Basic Company Detail
11.9.2 Bio Basic Business Overview
11.9.3 Bio Basic Custom Oligonucleotide Synthesis Service Introduction
11.9.4 Bio Basic Revenue in Custom Oligonucleotide Synthesis Service Business (2019-2024)
11.9.5 Bio Basic Recent Development
11.10 Kaneka Eurogentec SA
11.10.1 Kaneka Eurogentec SA Company Detail
11.10.2 Kaneka Eurogentec SA Business Overview
11.10.3 Kaneka Eurogentec SA Custom Oligonucleotide Synthesis Service Introduction
11.10.4 Kaneka Eurogentec SA Revenue in Custom Oligonucleotide Synthesis Service Business (2019-2024)
11.10.5 Kaneka Eurogentec SA Recent Development
11.11 AltaBioscience
11.11.1 AltaBioscience Company Detail
11.11.2 AltaBioscience Business Overview
11.11.3 AltaBioscience Custom Oligonucleotide Synthesis Service Introduction
11.11.4 AltaBioscience Revenue in Custom Oligonucleotide Synthesis Service Business (2019-2024)
11.11.5 AltaBioscience Recent Development
11.12 Synbio Technologies
11.12.1 Synbio Technologies Company Detail
11.12.2 Synbio Technologies Business Overview
11.12.3 Synbio Technologies Custom Oligonucleotide Synthesis Service Introduction
11.12.4 Synbio Technologies Revenue in Custom Oligonucleotide Synthesis Service Business (2019-2024)
11.12.5 Synbio Technologies Recent Development
11.13 TriLink
11.13.1 TriLink Company Detail
11.13.2 TriLink Business Overview
11.13.3 TriLink Custom Oligonucleotide Synthesis Service Introduction
11.13.4 TriLink Revenue in Custom Oligonucleotide Synthesis Service Business (2019-2024)
11.13.5 TriLink Recent Development
11.14 Azenta Life Science
11.14.1 Azenta Life Science Company Detail
11.14.2 Azenta Life Science Business Overview
11.14.3 Azenta Life Science Custom Oligonucleotide Synthesis Service Introduction
11.14.4 Azenta Life Science Revenue in Custom Oligonucleotide Synthesis Service Business (2019-2024)
11.14.5 Azenta Life Science Recent Development
11.15 KareBay Biochem
11.15.1 KareBay Biochem Company Detail
11.15.2 KareBay Biochem Business Overview
11.15.3 KareBay Biochem Custom Oligonucleotide Synthesis Service Introduction
11.15.4 KareBay Biochem Revenue in Custom Oligonucleotide Synthesis Service Business (2019-2024)
11.15.5 KareBay Biochem Recent Development
11.16 Creative Biogene
11.16.1 Creative Biogene Company Detail
11.16.2 Creative Biogene Business Overview
11.16.3 Creative Biogene Custom Oligonucleotide Synthesis Service Introduction
11.16.4 Creative Biogene Revenue in Custom Oligonucleotide Synthesis Service Business (2019-2024)
11.16.5 Creative Biogene Recent Development
11.17 Generi Biotech
11.17.1 Generi Biotech Company Detail
11.17.2 Generi Biotech Business Overview
11.17.3 Generi Biotech Custom Oligonucleotide Synthesis Service Introduction
11.17.4 Generi Biotech Revenue in Custom Oligonucleotide Synthesis Service Business (2019-2024)
11.17.5 Generi Biotech Recent Development
11.18 Primetech
11.18.1 Primetech Company Detail
11.18.2 Primetech Business Overview
11.18.3 Primetech Custom Oligonucleotide Synthesis Service Introduction
11.18.4 Primetech Revenue in Custom Oligonucleotide Synthesis Service Business (2019-2024)
11.18.5 Primetech Recent Development
11.19 General Biosystems
11.19.1 General Biosystems Company Detail
11.19.2 General Biosystems Business Overview
11.19.3 General Biosystems Custom Oligonucleotide Synthesis Service Introduction
11.19.4 General Biosystems Revenue in Custom Oligonucleotide Synthesis Service Business (2019-2024)
11.19.5 General Biosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
GenScript
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Creative Biolabs
Bio Basic
Kaneka Eurogentec SA
AltaBioscience
Synbio Technologies
TriLink
Azenta Life Science
KareBay Biochem
Creative Biogene
Generi Biotech
Primetech
General Biosystems
听
听
*If Applicable.
